Dr. Khalil Sultanem, MD
Claim this profileJewish General Hospital
Studies Squamous Cell Carcinoma
Studies Oropharyngeal Cancer
6 reported clinical trials
15 drugs studied
Area of expertise
1Squamous Cell Carcinoma
p16 positive
p16 negative
2Oropharyngeal Cancer
Stage I
Stage II
p16 positive
Affiliated Hospitals
Clinical Trials Khalil Sultanem, MD is currently running
SABR Boost + Short-course Radiation
for Oropharyngeal Cancer
This is a randomized clinical trial comparing the outcomes of short-course chemoradiation consisting in stereotactic boost to the gross tumor and de-esclalated chemoradiation to the elective neck in human papilloma associated oropharynx cancer vs. the current standard 7-week course chemoradiation.
Recruiting1 award Phase 29 criteria
NBTXR3 +/− Cetuximab
for Head and Neck Cancer
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy/performance and safety of NBTXR3/RT±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with LA-HNSCC.
Recruiting2 awards Phase 319 criteria
More about Khalil Sultanem, MD
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Khalil Sultanem, MD has experience with
- Cisplatin
- Radiation
- SABR Boost And De-escalated Chemoradiation
- Standard Chemoradiation
- Fluorouracil
- Gemcitabine Hydrochloride
Breakdown of trials Khalil Sultanem, MD has run
Squamous Cell Carcinoma
Oropharyngeal Cancer
Head and Neck Cancers
Mouse Papillomavirus
Human Papillomavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Khalil Sultanem, MD specialize in?
Khalil Sultanem, MD focuses on Squamous Cell Carcinoma and Oropharyngeal Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved p16 positive patients, or patients who are p16 negative.
Is Khalil Sultanem, MD currently recruiting for clinical trials?
Yes, Khalil Sultanem, MD is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Khalil Sultanem, MD has studied deeply?
Yes, Khalil Sultanem, MD has studied treatments such as Cisplatin, Radiation, SABR boost and de-escalated chemoradiation.
What is the best way to schedule an appointment with Khalil Sultanem, MD?
Apply for one of the trials that Khalil Sultanem, MD is conducting.
What is the office address of Khalil Sultanem, MD?
The office of Khalil Sultanem, MD is located at: Jewish General Hospital, Montreal, Quebec H3T 1E2 Canada. This is the address for their practice at the Jewish General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.